MOLECULIN BIOTECH, INC.

Insiders Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Delayed Nasdaq Other stock markets 03:52:18 2024-04-29 pm EDT			5-day change	1st Jan Change
4.93 ^USD	+6.48%		+14.65%	-61.71%

Apr. 18	Sector Update: Health Care Stocks Ease in Afternoon Trading	MT
Apr. 18	Moleculin Biotech Secures Orphan Drug Label For Annamycin in EU	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Moleculin Biotech, Inc. Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer	22-05-04	CI
Moleculin Biotech, Inc. Announces Appointment of Joy Yan, M.D., Ph.D. to Board of Directors	22-03-01	CI
Moleculin Biotech, Inc. Appoints Elizabeth Cermak to Board of Directors	20-10-05	CI
Moleculin Biotech, Inc. Appoints Richard Whitley to its Science Advisory Board	20-04-22	CI
Moleculin Biotech, Inc Appoints Hongbo Zhai to its Science Advisory Board	20-03-10	CI
Moleculin Biotech, Inc Appoints Martin Tallman to its Science Advisory Board	19-03-18	CI
Moleculin Announces Dr. James L. Abbruzzese Joins Science Advisory Board	19-01-17	CI
Jorge Cortes and Elihu Estey Join Moleculin Biotech, Inc.'s Science Advisory Board	18-01-17	CI
Moleculin Biotech, Inc. Appoints Sandra Silberman as Chief Medical Officer	17-11-08	CI
Moleculin Biotech, Inc. Announces Executive Changes	17-08-25	CI
Moleculin Biotech, Inc. Announces Resignation of Jacqueline Northcut as Company’s Board of Directors	17-07-27	CI
Moleculin Biotech, Inc. Appoints John M. Climaco as an Independent Member of the Board of Directors	17-07-27	CI
Moleculin Biotech, Inc. Announces Scientific Advisory Board Appointments	17-01-19	CI
Moleculin Biotech, Inc. Appoints Jonathan P. Foster as Executive Vice President and Chief Financial Officer	16-08-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer